Moderna could offer a low risk buying opportunity
[ad_1] Moderna Inc. (MRNA) fell 11.4% on Friday after component Dow Merck and Co. Inc. (MRK) reported positive clinical results for a pill aimed at reducing hospitalizations and deaths from COVID-19 . If emergency use is approved, patients will be able to take the pill after infection, but it will not replace the billions of … Read more